ADLYXIN

Brand name authorized in: United States

Active ingredients

The drug ADLYXIN contains one active pharmaceutical ingredient (API):

1 Lixisenatide
UNII 74O62BB01U - LIXISENATIDE

Lixisenatide is a selective GLP-1 receptor agonist. The GLP-1 receptor is the target for native GLP-1, an endogenous incretin hormone that potentiates glucose-dependent insulin secretion from the pancreatic beta cells.

Read about Lixisenatide

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
US
FDA, National Drug Code
Identifier(s): 0024-5747